Paper30554657
Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer.
Hayashi F and 9 others. Biochem Biophys Res Commun, 2019. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer. Papers, record 30554657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30554657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrier Proteins | Major topic |
| Mouth Neoplasms | Major topic |
| Cell Cycle | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Male | |
| Middle Aged | |
| RNA, Messenger | |
| Resveratrol |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42360372 | Zinc finger protein-associated gene signature serves as a potential predictor for prognosis and therapeutic response in lung adenocarcinoma. | Amino Acids | 2026 | https://conductscience.org/library/papers/42360372 | PubMed |
| 42358819 | Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities. | Oncol Res | 2026 | https://conductscience.org/library/papers/42358819 | PubMed |
| 41226384 | Roles of Selected Bioactive Compounds in Inhibiting the Development and Progression of Cancer-A Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226384 | PubMed |
| 40276014 | LINC02679 regulates TRIML2 to promote gastric cancer proliferation and invasion via targeting miR-5004-3p. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/40276014 | PubMed |
| 40110305 | The function of TRIML2 on the temozolomide resistance in glioblastoma. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40110305 | PubMed |
| 39327393 | Sex differences in human pre-gastrulation embryos. | Sci China Life Sci | 2025 | https://conductscience.org/library/papers/39327393 | PubMed |
| 38987730 | Effect and mechanism of resveratrol on ferroptosis mediated by p53/SLC7A11 in oral squamous cell carcinoma. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/38987730 | PubMed |
| 38850799 | Integration RNA bulk and single cell RNA sequencing to explore the change of glycolysis-related immune microenvironment and construct prognostic signature in head and neck squamous cell carcinoma. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38850799 | PubMed |
| 38575921 | A systematic review and meta-analysis of the impact of resveratrol on oral cancer: potential therapeutic implications. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/38575921 | PubMed |
| 37142983 | Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37142983 | PubMed |
| 36685979 | Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma. | Front Genet | 2022 | https://conductscience.org/library/papers/36685979 | PubMed |
| 34992682 | Aberrant GIMAP2 expression affects oral squamous cell carcinoma progression by promoting cell cycle and inhibiting apoptosis. | Oncol Lett | 2022 | https://conductscience.org/library/papers/34992682 | PubMed |
| 34939038 | Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment. | Nat Cancer | 2021 | https://conductscience.org/library/papers/34939038 | PubMed |
| 34830778 | Characterization of Recurrent Relevant Genes Reveals a Novel Role of RPL36A in Radioresistant Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34830778 | PubMed |
| 34273003 | Resveratrol effects in oral cancer cells: a comprehensive review. | Med Oncol | 2021 | https://conductscience.org/library/papers/34273003 | PubMed |
| 34179310 | Tumor suppressor p53 cross-talks with TRIM family proteins. | Genes Dis | 2021 | https://conductscience.org/library/papers/34179310 | PubMed |
| 32486484 | Wine Consumption and Oral Cavity Cancer: Friend or Foe, Two Faces of Janus. | Molecules | 2020 | https://conductscience.org/library/papers/32486484 | PubMed |
| 32226386 | The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32226386 | PubMed |
| 31633784 | Eutherian-Specific Gene TRIML2 Attenuates Inflammation in the Evolution of Placentation. | Mol Biol Evol | 2020 | https://conductscience.org/library/papers/31633784 | PubMed |
| 30974870 | Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer? | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30974870 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CDK4 | 1019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
| CDK6 | 1021 | PubTator's text mining | https://conductscience.org/library/genes/1021 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| CDKN1B | 1027 | PubTator's text mining | https://conductscience.org/library/genes/1027 | NCBI Gene |
| TRIML2 | 205860 | PubTator's text mining | https://conductscience.org/library/genes/205860 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30554657
GET https://conductscience.org/api/papers/v1/30554657/authors